Suchergebnisse - (Subject:"2019-nCoV")

PubPharm (981)

51

COVID-19 Australia : Epidemiology Report 75: Reporting period ending 4 June 2023

enthalten in: Communicable diseases intelligence (2018) | 2023

von COVID-19 Epidemiology and Surveillance Team

52

Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity : A Quality-Adjusted Life Years Analysis

enthalten in: American journal of epidemiology | 2023

von Kitano, T. | Thompson, D. | Engineer, L. | +2

CommentIn: Am J Epidemiol. 2023 Jun 2;192(6):1031. - PMID 36958820

53

Similar Time Course of Humoral Response to SARS-CoV-2 mRNA Vaccines in People With and Without Type 1 Diabetes

enthalten in: Diabetes technology & therapeutics | 2023

von Jia, X. | Dong, F. | Pyle, L. | +3

54

Factors associated with receipt of mRNA-1273 vaccine at a United States national retail pharmacy during the COVID-19 pandemic

enthalten in: Vaccine | 2023

von Roberts-McCarthy, E. | Buck, P. | Smith-Ray, R. | +5

55

Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States : Interim results from an observational cohort study

enthalten in: Vaccine | 2023

von Ku, J. | Sy, L. | Qian, L. | +11

56

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination-A nationwide study

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2023

von Su, W. | Liu, Y. | Chang, C. | +12

57

Reactogenicity and safety of COVID-19 primary immunisation and booster vaccination regimens : a comparative observational cohort study

enthalten in: BMC medicine | 2023

von Warkentin, L. | Werner, F. | Zeschick, N. | +6

58

COVID-19 Australia : Epidemiology Report 74 - Reporting period ending 7 May 2023

enthalten in: Communicable diseases intelligence (2018) | 2023

von COVID-19 Epidemiology and Surveillance Team

59

COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs

enthalten in: Vaccine | 2023

von Jiang, M. | Väisänen, E. | Kolehmainen, P. | +5

60

Waning of 2-Dose BNT162b2 and mRNA-1273 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Accounting for Depletion-of-Susceptibles Bias

enthalten in: American journal of epidemiology | 2023

von Andrejko, K. | Pry, J. | Myers, J. | +10